XOMA (NASDAQ:XOMA – Get Free Report) released its quarterly earnings results on Monday. The biotechnology company reported ($0.46) EPS for the quarter, missing analysts’ consensus estimates of ($0.29) by ($0.17), Zacks reports. XOMA had a negative return on equity of 24.95% and a negative net margin of 151.34%.
XOMA Stock Up 1.4 %
XOMA stock traded up $0.29 during midday trading on Monday, reaching $20.73. The stock had a trading volume of 20,213 shares, compared to its average volume of 26,083. The stock has a market capitalization of $244.26 million, a P/E ratio of -5.96 and a beta of 1.00. The firm’s fifty day simple moving average is $24.85 and its 200-day simple moving average is $27.41. The company has a debt-to-equity ratio of 1.28, a quick ratio of 7.52 and a current ratio of 7.52. XOMA has a 1-year low of $19.92 and a 1-year high of $35.00.
Insiders Place Their Bets
In other XOMA news, major shareholder Bvf Partners L. P/Il sold 500,742 shares of XOMA stock in a transaction on Friday, January 24th. The shares were sold at an average price of $26.10, for a total value of $13,069,366.20. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 7.20% of the company’s stock.
Analyst Upgrades and Downgrades
Get Our Latest Stock Analysis on XOMA
About XOMA
XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.
Read More
- Five stocks we like better than XOMA
- How to Read Stock Charts for Beginners
- Can TikTok Stock Picks Really Make You Rich?
- CD Calculator: Certificate of Deposit Calculator
- The “Quality” Rotation: Back to Basics Investing
- Quiet Period Expirations Explained
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.